Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Open Studies | "Coronavirus Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Coronavirus Infections" (4 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
2 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:
3 Not yet recruiting MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Interventions: Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo
4 Recruiting Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Condition: Middle East Respiratory Syndrome Coronavirus
Interventions: Biological: SAB-301;   Other: Normal (9%) Saline

Indicates status has not been verified in more than two years